Panel: Opioid Suits Describe ‘Exclusively Deliberate’ Conduct, No Coverage Owed
SAN FRANCISCO — The Ninth Circuit U.S. Court of Appeals on Jan. 26 held that underlying allegations brought against a prescription drug distributor insured “describe exclusively deliberate conduct” and, therefore, there...To view the full article, register now.
Already a subscriber? Click here to view full article